Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: A retrospective study

Clinical and Experimental Hypertension

Volumn 32, Issue 2, 2010, Pages 137-144

  Cicero, Arrigo F G ^a   Derosa, Giuseppe ^b   Di Gregori, Valentina ^a   Bove, Marilisa ^a   Gaddi, Antonio V ^a   Borghi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Blood pressure; Fish oil; Hypertension; Omega 3 fatty acids; Polyunsaturated fatty acids

Indexed keywords

ATORVASTATIN; BEZAFIBRATE; FENOFIBRATE; FLUINDOSTATIN; LIPID; OMEGA 3 FATTY ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PULSE PRESSURE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 77950841455     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641960903254448     Document Type: Article

References (27)

1. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975;28:958-966.
2. Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: The Alaska Siberia Project. Int J Circumpolar Health 2005;64(4):396-408.
3. Mozaffarian D, Longstreth WT Jr, Lemaitre RN, et al. Fish consumption and stroke risk in elderly individuals: The cardiovascular health study. Arch Intern Med 2005;165(2):200-206.
4. Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC, et al. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J 2006;151(4):857-862.
5. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. Polyunsaturated PUFAs in the food chain in the United States. Am J Clin Nutr 2000;71:179S-188S.
6. Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother 2008;9(7):1237-1248.
7. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493-1499.
8. Borghi C, Cicero AFG. Blood pressure modulating properties of omega-3 polyunsaturated fatty acids (PUFA). Another PUFA heart protective effect? High Blood Press Cardiov Prev 2007;14(2):1-7.
9. Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC Task Force on the Management of Arterial Hypertension: 2007 ESHESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007;25(9):1751-1762.
10. Grundy SM, Cleeman JI, Merz CN, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110(2):227-239.
11. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005;111(5):697-716.
12. Derosa G, Fogari E, Cicero AFG, et al. Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin. Hypertens Res 2007;30(5):387-394.
13. Kris-Etherton PM, Harris WS, Appel LJ for the Nutrition Committee. AHA scientific statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-2757.
14. Wang C, Harris WS, Chung M, et al. n-3. fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary- prevention studies: A systematic review. Am J Clin Nutr 2006;84(1):5-17.
15. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83(6 suppl):1505S-1519S.
16. Kim JI, Tsujino T, Fujioka Y, Saito K, Yokoyama M. Bezafibrate improves hypertension and insulin sensitivity in humans. Hypertens Res 2003;26(4):307-313.
17. Tomiyama H, Takazawa K, Osa S, et al. Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia? A preliminary study. Hypertens Res 2005;28(8):651-655.
18. Engler MM, Engler MB, Pierson DM, Molteni LB, Molteni A. Effects of docosahexaenoic acid on vascular pathology an reactivity in hypertension. Exp Biol Med 2003;228:299-307.
19. Damsgaard CT, Frøkiaer H, Andersen AD, Lauritzen L. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 2008;138(6):1061-1066.
20. Barre DE. The role of consumption of alpha-linilenic, eicosapentaenoic and docoshaexaenoic acids in human metabolic syndrome and type 2 diabetes: a mini-review. J Oleo Sci 2007;56(7):319-325.
21. Hartweg J, Farmer AJ, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 2007;50(2):250-258.
22. Rossi R, Nuzzo A, Origliani G, Modena MG. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. Hypertension 2008;52(5):865-872.
23. Tomiyama H, Takazawa K, Osa S, et al. Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia? A preliminary study. Hypertens Res 2008;372(9645):1223-1230.
24. GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 2008;372(9645):1223-1230.
25. Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol 2006;33(9):842-846.
26. Borghi C. Interactions between hypercholesterolemia and hypertension: Implications for therapy. Curr Opin Nephrol Hypertens 2002;11(5):489-496.
27. Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A. Brisighella Heart Study Working Party. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J 2004;148(2):285-292.